Targovax selected for oral presentation at Society for Immunotherapy of Cancer (SITC) 2019 Annual Meeting
Title: A pilot study of engineered adenovirus ONCOS-102 in combination
with pembrolizumab in checkpoint inhibitor refractory advanced or
unresectable melanoma
Authors: Alexander N. Shoushtari, MD; Anthony J. Olszanski, MD, RPh; Thomas
J. Hornyak, MD; Jedd D. Wolchok, MD, PhD; Sylvia Vetrhus; Karianne
Risberg Handeland; Lukasz Kuryk, PhD; Magnus Jaderberg, MD;
Date: 9 November 2019
Time: 5:30 pm - 5:45 pm
Presenter: Dr. Alexander Shoushtari, Principal Investigator, MSKCC, NYC